Trial intelligence / Profile preview

Glecaprevir/pibrentasvir in adults with chronic hepatitis C genotype 5 or 6

2016-003192-22Phase 3Completed

Sponsor

AbbVie Inc.

Start

Dec 2016

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1